Hypokalemia: Difference between revisions
(Major update: severity-based replacement protocol, IV rates/concentrations, magnesium correction requirement, DKA K thresholds, ECG changes, digoxin interaction, references with PMIDs) |
(Add reference) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Serum potassium | *Serum potassium <3.5 mEq/L | ||
* | *Most common electrolyte abnormality encountered in clinical practice | ||
*Severity: | *Severity: | ||
**Mild: 3.0-3.5 mEq/L | **Mild: 3.0-3.5 mEq/L | ||
**Moderate: 2.5-3.0 mEq/L | **Moderate: 2.5-3.0 mEq/L | ||
** | **Severe: <2.5 mEq/L (risk of arrhythmia, respiratory failure) | ||
* | *Every 1 mEq/L decrease in serum K represents ~200-400 mEq total body deficit | ||
===Causes=== | ===Causes=== | ||
* | *Decreased intake: malnutrition, anorexia, alcoholism | ||
* | *GI losses (most common): | ||
**Vomiting (metabolic alkalosis → renal K wasting) | **Vomiting (metabolic alkalosis → renal K wasting) | ||
**Diarrhea (direct K loss) | **Diarrhea (direct K loss) | ||
**NG suction, laxative abuse | **NG suction, laxative abuse | ||
* | *Renal losses: | ||
** | **Diuretics (loops, thiazides — most common medication cause) | ||
**Hyperaldosteronism (primary or secondary) | **Hyperaldosteronism (primary or secondary) | ||
**[[Renal tubular acidosis]] (types 1 and 2) | **[[Renal tubular acidosis]] (types 1 and 2) | ||
**Hypomagnesemia (impairs renal K conservation) | **Hypomagnesemia (impairs renal K conservation) | ||
**Osmotic diuresis ([[DKA]]) | **Osmotic diuresis ([[DKA]]) | ||
* | *Transcellular shift (K moves into cells): | ||
** | **Insulin (therapeutic or endogenous) | ||
** | **Beta-2 agonists (albuterol) | ||
**Alkalosis | **Alkalosis | ||
**Catecholamine surge, thyrotoxicosis | **Catecholamine surge, thyrotoxicosis | ||
| Line 28: | Line 28: | ||
==Clinical Features== | ==Clinical Features== | ||
*Often | *Often asymptomatic with mild hypokalemia | ||
* | *Muscle weakness (proximal > distal), cramps, myalgia | ||
*Ileus, constipation, nausea/vomiting | *Ileus, constipation, nausea/vomiting | ||
* | *Rhabdomyolysis (severe hypokalemia) | ||
* | *Cardiac arrhythmias: | ||
**PACs, PVCs → atrial or ventricular [[tachycardia]] → | **PACs, PVCs → atrial or ventricular [[tachycardia]] → torsades de pointes → VF | ||
** | **Potentiates [[digoxin toxicity]] | ||
===ECG Changes=== | ===ECG Changes=== | ||
* | *Flattened T waves (earliest) | ||
* | *Prominent U waves (after T wave) | ||
* | *ST depression | ||
*Prolonged QT interval | *Prolonged QT interval | ||
* | *T-U fusion (severe) | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 54: | Line 54: | ||
==Evaluation== | ==Evaluation== | ||
* | *ECG (look for U waves, flattened T waves, prolonged QT) | ||
* | *BMP: K level, bicarbonate (alkalosis?), glucose, creatinine | ||
* | *Magnesium level (hypokalemia refractory to replacement if Mg not corrected) | ||
* | *Calcium level (concurrent abnormalities) | ||
*Consider: urine K (spot urine K/Cr ratio or 24h K), urine chloride, TSH, cortisol/aldosterone if unexplained | *Consider: urine K (spot urine K/Cr ratio or 24h K), urine chloride, TSH, cortisol/aldosterone if unexplained | ||
* | *Digoxin level if on digoxin (hypokalemia increases digoxin sensitivity) | ||
==Management== | ==Management== | ||
===Guiding Principles=== | ===Guiding Principles=== | ||
* | *Always check and replace magnesium first — hypokalemia is refractory to correction with concurrent hypomagnesemia | ||
*Oral replacement preferred when possible (better tolerated, less risky) | *Oral replacement preferred when possible (better tolerated, less risky) | ||
*IV replacement for severe hypokalemia, ECG changes, or NPO patients | *IV replacement for severe hypokalemia, ECG changes, or NPO patients | ||
===Mild Hypokalemia (3.0-3.5 mEq/L)=== | ===Mild Hypokalemia (3.0-3.5 mEq/L)=== | ||
* | *Oral KCl 20-40 mEq PO q2-4h (typical total dose 40-100 mEq/day) | ||
*Increase dietary potassium | *Increase dietary potassium | ||
===Moderate Hypokalemia (2.5-3.0 mEq/L)=== | ===Moderate Hypokalemia (2.5-3.0 mEq/L)=== | ||
* | *KCl 10-20 mEq/hr IV via peripheral line (max 40 mEq/L concentration peripherally) | ||
**Higher concentrations require | **Higher concentrations require central line | ||
* | *Max infusion rate: 10-20 mEq/hr (peripheral); up to 40 mEq/hr via central line with cardiac monitoring | ||
*Concurrent oral supplementation | *Concurrent oral supplementation | ||
===Severe Hypokalemia (<2.5 mEq/L or ECG Changes)=== | ===Severe Hypokalemia (<2.5 mEq/L or ECG Changes)=== | ||
* | *Continuous cardiac monitoring | ||
* | *KCl 20-40 mEq/hr IV via central line | ||
* | *Magnesium sulfate 2g IV (if Mg not checked yet, give empirically) | ||
*Recheck K every 1-2 hours | *Recheck K every 1-2 hours | ||
*May require | *May require 200+ mEq total replacement | ||
===Special Situations=== | ===Special Situations=== | ||
* | *[[DKA]]: K may be normal or elevated on presentation but total body stores are depleted | ||
**Replace K ''before or concurrent with insulin'' when K <5.3 | **Replace K ''before or concurrent with insulin'' when K <5.3 | ||
**'''Do NOT start insulin if K <3.3''' — replace K to >3.3 first | **'''Do NOT start insulin if K <3.3''' — replace K to >3.3 first | ||
* | *[[Digoxin toxicity]]: maintain K >4.0 mEq/L | ||
* | *Refractory hypokalemia: check and replace magnesium<ref>Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649-2652. PMID 17804670</ref>; consider amiloride or spironolactone | ||
==Disposition== | ==Disposition== | ||
* | *Admit if K <2.5, symptomatic, ECG changes, arrhythmia, or ongoing losses | ||
* | *Continuous telemetry for K <3.0 or ECG changes | ||
* | *Discharge if mild (3.0-3.5), asymptomatic, clear correctable cause, tolerated PO replacement, normal ECG | ||
*Close follow-up with recheck in 24-48 hours | *Close follow-up with recheck in 24-48 hours | ||
Latest revision as of 10:06, 22 March 2026
Background
- Serum potassium <3.5 mEq/L
- Most common electrolyte abnormality encountered in clinical practice
- Severity:
- Mild: 3.0-3.5 mEq/L
- Moderate: 2.5-3.0 mEq/L
- Severe: <2.5 mEq/L (risk of arrhythmia, respiratory failure)
- Every 1 mEq/L decrease in serum K represents ~200-400 mEq total body deficit
Causes
- Decreased intake: malnutrition, anorexia, alcoholism
- GI losses (most common):
- Vomiting (metabolic alkalosis → renal K wasting)
- Diarrhea (direct K loss)
- NG suction, laxative abuse
- Renal losses:
- Diuretics (loops, thiazides — most common medication cause)
- Hyperaldosteronism (primary or secondary)
- Renal tubular acidosis (types 1 and 2)
- Hypomagnesemia (impairs renal K conservation)
- Osmotic diuresis (DKA)
- Transcellular shift (K moves into cells):
- Insulin (therapeutic or endogenous)
- Beta-2 agonists (albuterol)
- Alkalosis
- Catecholamine surge, thyrotoxicosis
- Hypothermia (shifts K intracellularly)
Clinical Features
- Often asymptomatic with mild hypokalemia
- Muscle weakness (proximal > distal), cramps, myalgia
- Ileus, constipation, nausea/vomiting
- Rhabdomyolysis (severe hypokalemia)
- Cardiac arrhythmias:
- PACs, PVCs → atrial or ventricular tachycardia → torsades de pointes → VF
- Potentiates digoxin toxicity
ECG Changes
- Flattened T waves (earliest)
- Prominent U waves (after T wave)
- ST depression
- Prolonged QT interval
- T-U fusion (severe)
Differential Diagnosis
- Medication-induced (diuretics, insulin, albuterol)
- GI losses (vomiting, diarrhea)
- Diabetic ketoacidosis (total body K depleted despite possible normal level)
- Hyperaldosteronism
- Renal tubular acidosis
- Hypomagnesemia
- Bartter/Gitelman syndrome
- Thyrotoxic periodic paralysis
Evaluation
- ECG (look for U waves, flattened T waves, prolonged QT)
- BMP: K level, bicarbonate (alkalosis?), glucose, creatinine
- Magnesium level (hypokalemia refractory to replacement if Mg not corrected)
- Calcium level (concurrent abnormalities)
- Consider: urine K (spot urine K/Cr ratio or 24h K), urine chloride, TSH, cortisol/aldosterone if unexplained
- Digoxin level if on digoxin (hypokalemia increases digoxin sensitivity)
Management
Guiding Principles
- Always check and replace magnesium first — hypokalemia is refractory to correction with concurrent hypomagnesemia
- Oral replacement preferred when possible (better tolerated, less risky)
- IV replacement for severe hypokalemia, ECG changes, or NPO patients
Mild Hypokalemia (3.0-3.5 mEq/L)
- Oral KCl 20-40 mEq PO q2-4h (typical total dose 40-100 mEq/day)
- Increase dietary potassium
Moderate Hypokalemia (2.5-3.0 mEq/L)
- KCl 10-20 mEq/hr IV via peripheral line (max 40 mEq/L concentration peripherally)
- Higher concentrations require central line
- Max infusion rate: 10-20 mEq/hr (peripheral); up to 40 mEq/hr via central line with cardiac monitoring
- Concurrent oral supplementation
Severe Hypokalemia (<2.5 mEq/L or ECG Changes)
- Continuous cardiac monitoring
- KCl 20-40 mEq/hr IV via central line
- Magnesium sulfate 2g IV (if Mg not checked yet, give empirically)
- Recheck K every 1-2 hours
- May require 200+ mEq total replacement
Special Situations
- DKA: K may be normal or elevated on presentation but total body stores are depleted
- Replace K before or concurrent with insulin when K <5.3
- Do NOT start insulin if K <3.3 — replace K to >3.3 first
- Digoxin toxicity: maintain K >4.0 mEq/L
- Refractory hypokalemia: check and replace magnesium[1]; consider amiloride or spironolactone
Disposition
- Admit if K <2.5, symptomatic, ECG changes, arrhythmia, or ongoing losses
- Continuous telemetry for K <3.0 or ECG changes
- Discharge if mild (3.0-3.5), asymptomatic, clear correctable cause, tolerated PO replacement, normal ECG
- Close follow-up with recheck in 24-48 hours
See Also
References
- Kardalas E, et al. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135-R146. PMID 29540487
- Gennari FJ. Hypokalemia. N Engl J Med. 1998;339(7):451-458. PMID 9700180
- Viera AJ, Wouk N. Potassium disorders: hypokalemia and hyperkalemia. Am Fam Physician. 2015;92(6):487-495. PMID 26371733
- Crop MJ, et al. Role of magnesium in hypokalemia. Crit Care. 2012;16(1):229. PMID 22866973
- ↑ Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649-2652. PMID 17804670
